Observational Study
Copyright ©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 2137-2149
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2137
Table 3 Hepatitis virus B and C infections in the three study groups
Variable
HCC (n = 34), (%)
Chronic liver infection (n = 11), (%)
Control (n = 5), (%)
(X2)1
P value
HCVAbPositive30 (88.2)11 (100.0)0 (0.0)18.32 FE< 0.001 HS
Negative4 (11.8)0 (0.0)5 (100.0)
HBsAgPositive2 (5.9)0 (0.0)0 (0.0)0.78 FE1.00 NS
Negative32 (94.1)11 (100.0)5 (100.0)